CYPRESS BIOSCIENCE INC
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 16, 2010
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Director / officer changeDec 22, 2010
- Entered a material agreement · Modified shareholder rightsDec 16, 2010
- Other material eventDec 15, 2010
- Results of operationsNov 9, 2010
- Other material eventOct 8, 2010
- Entered a material agreement · Modified shareholder rightsSep 28, 2010
- Regulation FD disclosureSep 15, 2010
- Delisting / listing-standard noticeAug 31, 2010
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AAQR CAPITAL MANAGEMENT LLCFeb 8, 2012
- CT ORDERDec 29, 2011
- SC 13G/ASCHEDULE 13G/AFeb 14, 2011
- SC 13G/ASEC FILINGFeb 14, 2011
- SC 13GAQR CAPITAL MANAGEMENT LLCFeb 11, 2011
- SC 13G/AFeb 4, 2011
- EFFECTJan 18, 2011
- EFFECTJan 18, 2011
- EFFECTJan 18, 2011
- EFFECTJan 18, 2011
- 15-12GFORM 15-12GJan 14, 2011
- POS AMJan 14, 2011
- POS AMFORM POS AMJan 14, 2011
- POS AMJan 14, 2011
- POS AMFORM POS AMJan 14, 2011
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.